Intracorneal Ring Segments

Back

Background

More than 20 million people in the United States have myopia between 1.00 and 3.00 diopters (D) with astigmatism of 1.00 D or less. Several options for visual rehabilitation are available to each individual, including spectacle correction, contact lens fitting, refractive keratotomy (RK), photorefractive keratectomy (PRK)[1] , laser-assisted in situ keratomileusis (LASIK)[2, 3] , and intracorneal rings, as shown below.[4, 5] Currently, nonsurgical approaches are still the least expensive and safest. For the subset of patients who desire freedom from glasses and lenses, refractive surgery is an option.[6, 7, 8]



View Image

Graphic representation of the intracorneal ring segments in place. Reprinted with permission of Addition Technology Inc.



View Image

Intacs microthin prescription inserts treat mild myopia. Reprinted with permission of Addition Technology Inc.

The ideal refractive surgery procedure is one that is effective, predictable, safe, and potentially reversible.[9, 10] The goal of this article is to present a refractive surgical procedure in which implantation of a polymethyl methacrylate (PMMA) ring or ring segments in the peripheral corneal stroma is used to correct myopia and astigmatism.[11] What initially was limited to the correction of myopia and astigmatism is now being primarily used for the management of postrefractive laser surgery associated corneal ectasia and keratoconus.[12, 13, 14, 15, 16]

Device description

The intrastromal corneal ring (ICR) is a device designed to correct mild-to-moderate myopia by flattening the anterior corneal curvature without encroaching on the visual axis. The device is an open-ended PMMA transparent ring with an outer diameter (R2) of 8.1 mm and an inner diameter (R1) of 6.8 mm, and the curvature conforms to that of the cornea. It is precision lathe-cut to ±0.01 mm as a hexagonal-shaped section of a cone with positioning holes for manipulation.[17] It is inserted through a peripheral radial incision made with a diamond knife at two-thirds corneal depth in to a 360° peripheral intrastromal channel created with specially designed instruments. Anterior corneal curvature is changed by using rings of different thicknesses.[18]

Intrastromal corneal ring segments (Intacs microthin prescription inserts, as shown below), or ICRS, are a more recent design modification of the ICR. The ring segments split the ring into two 150° arcs.[19] The use of ring segments simplifies the implantation procedure. Furthermore, ring segments can be placed away from the radial incision, thereby minimizing the potential for incision-related complications. The degree of correction (greater-thicker) is determined by the thickness of the Intacs inserts, which are available in 5 sizes: 0.25 mm, 0.275 mm, 0.30 mm, 0.325 mm, and 0.35 mm.[20, 21, 22]



View Image

KeraVision Intacs microthin prescription inserts. Reprinted with permission of Addition Technology Inc.



View Image

KeraVision Intacs microthin prescription inserts. Intracorneal ring segments. Reprinted with permission of Addition Technology Inc.

MediPhacos KeraRing is another intracorneal ring segment developed and marketed in Brazil. It is available in 2 models for 5-mm implantation in optical zones of 5 mm, 5.5 mm, and 6 mm. There are 40 different variations of thicknesses, arc lengths, and diameters, allowing for enhanced customization of corneal remodeling and refractive correction. Over 150,000 implants have been used worldwide.

Ferrara Ring is made of yellow PMMA, an inert and biocompatible acrylic used in intracorneal implants. The apical diameters are 5 mm and 6 mm. It has a flat base with a variable arch length of 90 mm and 210 mm and a variable thickness of 0.15 mm to 0.30 mm.

Surgical instruments

Addition Technology has surgical instruments specifically for use with Intacs insertion. These instruments include the following: corneal thickness gauges, glides, incision and placement marker, pocketing hook, pocketing lever, ring forceps, stromal spreader, vacuum-centering guide with vacuum system, and clockwise and counterclockwise dissectors.[23]

Ferrara Ring has its own surgical kit used in the insertion of the intracorneal ring segments. These instruments include the following: Ferrara spatula, Suarez spreader, Bicalho guide, Pre-delaminator, Ferrara marker, Sinskey hook of 0.20 mm, Modified McPherson forceps, and an adjustable Ferrara diamond blade knife.[24]

How do intracorneal ring segment inserts work?

Imagine the cornea as compressed arcs of fiber covering the eye. If a spacer element is inserted between those fibers, effectively pushing them apart, then the arc must flatten to accommodate the inserted element. The corneal ring complies with Barraquer and Blavatskaya postulates. According to these postulates, an addition in the cornea periphery results in its flattening, and the ring diameter determines how much the cornea will be flattened. In other words, the more tissue is added (increasing ring thickness) and the smaller the diameter, the greater will be the myopia correction obtained. Intracorneal ring segments inserts shorten the corneal cord length, produce flattening across the entire cornea, and maintain the positive asphericity of the cornea.[25]

Advantages of intracorneal ring segment inserts

Several benefits of using intracorneal ring segment inserts exist. It is a minimally invasive outpatient procedure with low morbidity. Since the surgery is completed in the peripheral cornea, the central optical zone is not disturbed. Results are rapid and predictable. There is a reduced risk of visual adverse effects and a long-term convenient refractive correction. It is removable and exchangeable. There is central and peripheral flattening of the cornea, maintaining corneal asphericity (prolate).[26]

Intracorneal ring segments may now be used to treat irregular steepening (irregular astigmatism) of the cornea caused by keratoconus.[27, 28] There is a stabilization or delay of cone progression. The intracorneal ring segment is made of acrylic, an inert and biocompatible material; therefore, there is lack of rejection. There is a high patient satisfaction rate. It is possible to combine with other procedures like contact lens fitting, corneal collagen cross-linking, PRK, phakic IOL implantation, and intraocular lenses. There is no evidence of any interference with a corneal transplant.

Disadvantages of intracorneal ring segment inserts

The technology is limited for use in low-to-moderate myopia with low astigmatism, corneal ectasia, and keratoconus.[29] It is still a relatively new technology with emerging complications (eg, diurnal fluctuations in visual acuity, stromal opacifications).[30, 31, 32, 33] Of further concern is the prolonged intraoperative elevated intraocular pressure.[34, 35]

History of the Procedure

The KeraVision Ring was conceived by A.E. Reynolds, OD, in 1978. Kera Associates formed in 1980 to develop the ICR and other concepts. In 1995, the first preclinical study on Reynolds' product was performed.[36]

In 1991, the first human clinical trials began in Brazil with 360° ICR. The rings were implanted in corneas of nonfunctional human eyes. Shortly thereafter, a similar study was performed in the United States. Implantation in sighted eyes in the United States was implemented in 1993 as part of a US Food and Drug Administration (FDA) regulated phase II study.[37]

Implantation in contralateral eyes began in 1994. Preliminary astigmatism study began in Brazil at this time. In 1995, the US phase II myopia trial began for 150° ICRS.[38] In 1996, the US phase III for -1.00 to -3.50 D of myopia began.[39] CE (Conformite Europeene) marking was granted, permitting the commercial sale of the ICR in the European Union. A Pan-European myopia study began for ICRS. In 1998, HPB approval was granted in Canada, while preliminary hyperopia studies were started in Mexico.[40]

A premarket approval (PMA) application was filed with the FDA. In 1999, the trade name Intacs inserts was adopted for commercial sales of the ICRS, and FDA approval was granted for the commercial sale of Intacs inserts for -1.00 to -3.00 D of myopia with less than -1.00 D of astigmatism in the United States. After a promising introduction into the refractive market, KeraVision, the maker of Intacs, experienced financial difficulties and eventually sold its assets to Addition Technology in April 2001. Since its introduction, however, the use of Intacs has expanded from the treatment of patients with low-to-moderate myopia with low astigmatism to the treatment of patients with keratoconus.[41]

Table 1. Evolution of Intacs Inserts



View Table

See Table

Addition Technology (Intacs) is the popular intracorneal ring segment used in Australia and the United States. In Europe, Ferrara Ring intracorneal ring segments are popular. Addition Technology was recently acquired by Ferrara Ring. Ferrara Ring has been in development since 1986 and over 100,000 implants have been used with excellent results.

Indications

According to the FDA, Intacs are intended for the reduction or elimination of mild myopia (-1.00 to -3.00 D spherical equivalent at the spectacle plane) in patients who are aged 21 years or older, in patients with documented stability of refraction as demonstrated by a change of less than or equal to 0.50 D for at least 12 months prior to the preoperative examination, and in patients where the astigmatic component is +1.00 D or less.

In 2004, Intacs was given humanitarian device approval by the FDA for use in patients with keratoconus. The inserts may now be used to reduce irregular steepening (irregular astigmatism) caused by keratoconus. Intacs inserts help restore clear vision in patients with keratoconus by flattening and repositioning the cornea. Intacs inserts are intended for patients with keratoconus who are no longer able to achieve adequate vision using contact lenses or glasses and for whom corneal transplantation is the only remaining option.[12]

Table 2. Predicted Nominal Correction and Recommended Prescribing Range



View Table

See Table

The main indication for the Ferrara Ring implant is for the management of progressive keratoconus (ie, with gradual decrease of uncorrected visual acuity [UCVA] and best-corrected visual acuity [BCVA] and progressive corneal steepening). The Ferrara Ring implant is also indicated in patients with unsatisfactory BCVA with glasses and intolerance to contact lenses and in post-LASIK corneal ectasia when there is worsening of the condition.

Relevant Anatomy

The cornea is a transparent, avascular tissue that is continuous with the opaque sclera and semitransparent conjunctiva. The cornea is covered by tear film on its anterior surface and bathed by aqueous humor on its posterior surface.[42]

In adults, the cornea measures 11-12 mm horizontally and 9-11 mm vertically. The average corneal thickness is 0.5 mm (500 µm) centrally and 0.7 mm (700 µm) peripherally.

Contraindications

Intracorneal ring segments are contraindicated in the following patients:

Intracorneal ring segments should not be used in patients with keratoconus who have any of the following characteristics:

Warnings include the following:

Precautions include the following:

Imaging Studies

Corneal topography

Corneal topography development provides surgeons with effortlessly understood color-coded maps of corneal curvature in addition to quantitative indexes of irregular astigmatism that correlate with potential visual acuity.

Modern instrumentation produces a videokeratograph, which generally is in the form of a color-coded contour map.

Different manufacturers use different methods (eg, Placido, 40 scanned slits, combination Placido and 40 scanned slits, phase modified laser holography, raster stereography).

The use of video keratography in the preoperative and postoperative evaluation of all patients undergoing refractive surgery is valuable.

Dual Scheimpflug analyzer

This is a high-precision optical system for corneal topography and 3-dimensional analysis of the anterior eye segment, based on a Revolving Dual Channel Scheimpflug Camera and a Placido Disk.

Placido imaging furnishes high accuracy curvature data.

Scheimpflug imaging is optimal for precise elevation data.

Other Tests

Pachymetry

The pachymeter (optical, ultrasonic) is used to measure corneal thickness.

Accurate determination of corneal thickness preoperatively allows the surgeon to set the depth of incision to two thirds of the measured result.

Orbscan II by Orbtek uses both 40 scanned slits and Placido methods to provide anterior and posterior corneal curvature in addition to data on corneal thickness.

Procedures

A manual corneal trephination set to create a corneal tunnel for intrastromal corneal ring segments has been available since the introduction of ICRS. Currently, most femtosecond laser units are able to create similar tunnels using a specific program. The femtosecond laser–created tunnels are more precise and result in less morbidity than the manual approach.

Medical Therapy

Medical therapy is limited to broad-spectrum topical antibiotics and corticosteroids for uncomplicated cases.

See Postoperative details and/or articles on ocular pharmacology for more information.

Surgical Therapy

See Intraoperative details for the surgical procedure.

Preoperative Details

The procedure for placement of the intrastromal ring and ring segments is similar, and both can be performed with topical anesthesia. The operative field is prepared, and the patient is prepared and draped in the usual sterile fashion for ophthalmic surgery. A lid speculum is used for globe exposure.

Intraoperative Details

Manual intrastromal corneal pocket creation

The corneal center is identified and marked with a Sinskey hook.

A 2-mm long epithelial impression is created at the 12-o'clock position, where the ring segments are to be placed at an 8-mm diameter optical zone.

A diamond blade, set at 65% of the peripheral corneal depth, is used to perform a radial incision along this mark. See the image below.



View Image

The 1.2-mm radial incision is made with a diamond knife at the edge of a 7-mm optical zone. The diamond knife is set for approximately two thirds of c....

A vacuum-centering guide is positioned relative to the central corneal indentation.

The vacuum is increased, and the guide is circumferentially adhered onto the perilimbal conjunctiva, stabilizing the globe. This device provides a guide for the dissector. The dissector is inserted into the radial incision, and blunt dissection of the cornea at two-thirds depth is performed in the clockwise and counterclockwise directions to create 2 stromal channels. See the image below.



View Image

Rotation of the dissector creates the tunnel in the peripheral cornea into which an Intacs insert will be placed. Reprinted with permission of Additio....

The vacuum is released, and the vacuum-centering guide is removed.

Ring segments are inserted through the radial incisions using special forceps and are positioned using a Sinskey hook nasally and temporally, such that the superior ends are approximately 3 mm apart. See the images below.



View Image

The first Intacs insert is placed in the tunnel. Reprinted with permission of Addition Technology Inc.

The incision is closed with 1 or 2 interrupted 11-0 nylon sutures.



View Image

An Intacs insert in place at approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.

Postoperative Details

Postoperatively, antibiotic-corticosteroid combination drops and/or ointment are used, and the speculum is removed. The eye may be covered overnight with a shield. Antibiotic-corticosteroid combination drops are used 4 times daily for 1 week. The sutures are removed 2 weeks postoperatively or longer if the incision is not healed adequately.

Follow-up

Patients are seen postoperatively on day 1, week 1, and months 1, 3, 6, and 12. The surgeon should watch for postoperative complications. An observations timeline has been outlined for potential complications. See Complications.

Complications

Complications include localized incision-related epithelial defects, epithelial plug formation, wound dehiscence, superficial neovascularization, surgically induced astigmatism, infiltrates in the channel, transient decreased corneal sensation, and delayed infectious keratitis.[49, 50] Other observations included haze and deposits around the intrastromal channel.

Observations timeline consists of the following:

Exchange or explantation

In selected patients with undercorrection or overcorrection, an exchange procedure can be done. In selected patients who are dissatisfied, an explantation procedure can be done. The procedures can be done with the patient using only topical anesthesia. The surgical steps are listed below:

Outcome and Prognosis

A summary of the safety and efficacy variables at 12 months after surgery is as follows:

Future and Controversies

Applications of intrastromal ring segments include the following:

Author

Manolette R Roque, MD, MBA, FPAO, Section Chief, Ocular Immunology and Uveitis, Department of Ophthalmology, Asian Hospital and Medical Center; Section Chief, Ocular Immunology and Uveitis, International Eye Institute, St Luke's Medical Center Global City; Senior Eye Surgeon, The LASIK Surgery Clinic; Director, AMC Eye Center, Alabang Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Barbara L Roque, MD, DPBO, FPAO, Senior Partner, Roque Eye Clinic; Chief of Service, Pediatric Ophthalmology and Strabismus Section, Department of Ophthalmology, Asian Hospital and Medical Center; Active Consultant Staff, International Eye Institute, St Luke's Medical Center Global City

Disclosure: Nothing to disclose.

Roberto Pineda, II, MD, Director, Refractive Surgery Service, Massachusetts Eye and Ear Infirmary; Associate Professor of Ophthalmology, Harvard Medical School

Disclosure: Received consulting fee from Amgen for review panel membership; Received consulting fee from Genzyme?Sanofi for review panel membership; Received consulting fee from Novartis for consulting; Received consulting fee from Beaver-Visitec for consulting.

Ruben Limbonsiong, MD,

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Louis E Probst, MD, MD, Medical Director, TLC Laser Eye Centers

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy, Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Disclosure: Nothing to disclose.

Additional Contributors

Daniel S Durrie, MD, Director, Department of Ophthalmology, Division of Refractive Surgery, University of Kansas Medical Center

Disclosure: Received grant/research funds from Alcon Labs for independent contractor; Received grant/research funds from Abbott Medical Optics for independent contractor; Received ownership interest from Acufocus for consulting; Received ownership interest from WaveTec for consulting; Received grant/research funds from Topcon for independent contractor; Received grant/research funds from Avedro for independent contractor; Received grant/research funds from ReVitalVision for independent contractor.

References

  1. Lovisolo CF, Fleming JF. Intracorneal ring segments for iatrogenic keratectasia after laser in situ keratomileusis or photorefractive keratectomy. J Refract Surg. 2002 Sep-Oct. 18(5):535-41. [View Abstract]
  2. Gomez L, Chayet A. Laser in situ keratomileusis results after intrastromal corneal ring segments (Intacs). Ophthalmology. 2001 Oct. 108(10):1738-43. [View Abstract]
  3. Guell JL, Velasco F, Sanchez SI, et al. Intracorneal ring segments after laser in situ keratomileusis. J Refract Surg. 2004 Jul-Aug. 20(4):349-55. [View Abstract]
  4. Cochener B, Le Floch-Savary G, Colin J. [Excimer photorefractive keratectomy (PRK) versus intrastromal corneal ring segments (ICRS) for correction of low myopia]. J Fr Ophtalmol. 2000 Sep. 23(7):663-78. [View Abstract]
  5. Davis EA, Hardten DR, Lindstrom RL. Laser in situ keratomileusis after intracorneal rings. Report of 5 cases. J Cataract Refract Surg. 2000 Dec. 26(12):1733-41. [View Abstract]
  6. Barbara A, Shehadeh-Masha'our R, Garzozi HJ. Intacs after laser in situ keratomileusis and photorefractive keratectomy. J Cataract Refract Surg. 2004 Sep. 30(9):1892-5. [View Abstract]
  7. Colin J, Velou S. Utilization of refractive surgery technology in keratoconus and corneal transplants. Curr Opin Ophthalmol. 2002 Aug. 13(4):230-4. [View Abstract]
  8. Guell JL. Are intracorneal rings still useful in refractive surgery?. Curr Opin Ophthalmol. 2005 Aug. 16(4):260-5. [View Abstract]
  9. Chan SM, Khan HN. Reversibility and exchangeability of intrastromal corneal ring segments. J Cataract Refract Surg. 2002 Apr. 28(4):676-81. [View Abstract]
  10. Duffey RJ, Leaming D. U.S. trends in refractive surgery: 2001 International Society of Refractive Surgery Survey. J Refract Surg. 2002 Mar-Apr. 18(2):185-8. [View Abstract]
  11. Asbell PA, Ucakhan OO, Durrie DS, et al. Adjustability of refractive effect for corneal ring segments. J Refract Surg. 1999 Nov-Dec. 15(6):627-31. [View Abstract]
  12. Colin J, Cochener B, Savary G, et al. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg. 2000 Aug. 26(8):1117-22. [View Abstract]
  13. Colin J, Cochener B, Savary G, et al. INTACS inserts for treating keratoconus: one-year results. Ophthalmology. 2001 Aug. 108(8):1409-14. [View Abstract]
  14. Alio J, Salem T, Artola A, et al. Intracorneal rings to correct corneal ectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2002 Sep. 28(9):1568-74. [View Abstract]
  15. Ertan A, Colin J. Intracorneal rings for keratoconus and keratectasia. J Cataract Refract Surg. 2007 Jul. 33(7):1303-14. [View Abstract]
  16. Ameerh MA, Hamad GI, Ababneh OH, Gharaibeh AM, Refai RM, Bdour MD. Ferrara ring segments implantation for treating keratoconus. Int J Ophthalmol. 2012. 5(5):586-90. [View Abstract]
  17. McDonald JE, Deitz DJ. Removal of Intacs with a fractured positioning hole. J Refract Surg. 2004 Mar-Apr. 20(2):182-3. [View Abstract]
  18. Fleming JF, Wan WL, Schanzlin DJ. The theory of corneal curvature change with the Intrastromal Corneal Ring. CLAO J. 1989 Apr-Jun. 15(2):146-50. [View Abstract]
  19. Sugar A. Correction of spherical myopia with a single 150-degree intrastromal corneal ring segment. J Cataract Refract Surg. 2004 May. 30(5):1127-9. [View Abstract]
  20. Burris TE, Ayer CT, Evensen DA, et al. Effects of intrastromal corneal ring size and thickness on corneal flattening in human eyes. Refract Corneal Surg. 1991 Jan-Feb. 7(1):46-50. [View Abstract]
  21. Ito M, Arai H, Fukumoto T, et al. INTACS before or after laser in situ keratomileusis: correction of thin corneas with moderately high myopia. J Refract Surg. 2004 Nov-Dec. 20(6):818-22. [View Abstract]
  22. Linebarger EJ, Song D, Ruckhofer J, et al. Intacs: the intrastromal corneal ring. Int Ophthalmol Clin. 2000 Summer. 40(3):199-208. [View Abstract]
  23. Rosen E, Kowalewski E. Instrument for initiating the corneal intrastromal channel for the insertion of Intacs. J Cataract Refract Surg. 2001 Sep. 27(9):1356-8. [View Abstract]
  24. Ferrara Ring surgical kit. Ferrara Ring. Available at http://www.ferrararing.com.br/en/products. Accessed: 08/15/2013.
  25. Holmes-Higgin DK, Baker PC, Burris TE, et al. Characterization of the aspheric corneal surface with intrastromal corneal ring segments. J Refract Surg. 1999 Sep-Oct. 15(5):520-8. [View Abstract]
  26. Burris TE, Holmes-Higgin DK, Silvestrini TA, et al. Corneal asphericity in eye bank eyes implanted with the intrastromal corneal ring. J Refract Surg. 1997 Sep-Oct. 13(6):556-67. [View Abstract]
  27. Colin J, Velou S. Implantation of Intacs and a refractive intraocular lens to correct keratoconus. J Cataract Refract Surg. 2003 Apr. 29(4):832-4. [View Abstract]
  28. Hellstedt T, Makela J, Uusitalo R, et al. Treating keratoconus with intacs corneal ring segments. J Refract Surg. 2005 May-Jun. 21(3):236-46. [View Abstract]
  29. Donnenfeld ED. Intacs vs LASIK for Low Myopia. AAO Refractive Surgery Subspecialty Day Manual. 2000.
  30. Baikoff G, Maia N, Poulhalec D, et al. [Diurnal variations of refraction and keratometry after intracorneal rings]. J Fr Ophtalmol. 1999 Mar. 22(2):169-75. [View Abstract]
  31. Barach D, Mortemousque B, Bertel F, et al. [Fluctuations in uncorrected visual acuity after refractive surgery using intra-stromal corneal rings]. J Fr Ophtalmol. 1999 Apr. 22(3):335-8. [View Abstract]
  32. Nio YK, Jansonius NM, Wijdh RH, et al. Effect of methods of myopia correction on visual acuity, contrast sensitivity, and depth of focus. J Cataract Refract Surg. 2003 Nov. 29(11):2082-95. [View Abstract]
  33. Twa MD, Hurst TJ, Walker JG, et al. Diurnal stability of refraction after implantation with intracorneal ring segments. J Cataract Refract Surg. 2000 Apr. 26(4):516-23. [View Abstract]
  34. Burris TE. Intrastromal corneal ring technology: results and indications. Curr Opin Ophthalmol. 1998 Aug. 9(4):9-14. [View Abstract]
  35. Tran DB, Zadok D, Carpenter M, et al. Intraocular pressure measurement in patients with intrastromal corneal ring segments. J Refract Surg. 1999 Jul-Aug. 15(4):441-3. [View Abstract]
  36. Grabner G, Ruckhofer J, Tratter C, et al. [The intrastromal corneal ring (KeraVision Ring, ICR, ICRS). A modern method for correcting minor myopia]. Wien Med Wochenschr. 1997. 147(12-13):309-21. [View Abstract]
  37. Assil KK, Barrett AM, Fouraker BD, et al. One-year results of the intrastromal corneal ring in nonfunctional human eyes. Intrastromal Corneal Ring Study Group. Arch Ophthalmol. 1995 Feb. 113(2):159-67. [View Abstract]
  38. Schanzlin DJ, Asbell PA, Burris TE, et al. The intrastromal corneal ring segments. Phase II results for the correction of myopia. Ophthalmology. 1997 Jul. 104(7):1067-78. [View Abstract]
  39. Twa MD, Karpecki PM, King BJ, et al. One-year results from the phase III investigation of the KeraVision Intacs. J Am Optom Assoc. 1999 Aug. 70(8):515-24. [View Abstract]
  40. Loarie TM. The migration offshore of U.S. medical technology innovation--what it means for U.S. physicians. J Refract Surg. 1997 Mar-Apr. 13(2):176-84. [View Abstract]
  41. Alió JL, Artola A, Hassanein A, et al. One or 2 Intacs segments for the correction of keratoconus. J Cataract Refract Surg. 2005 May. 31(5):943-53. [View Abstract]
  42. Kessler D, El-Shiaty AF, Wachler BS. Evaluation of tear film following Intacs for myopia. J Refract Surg. 2002 Mar-Apr. 18(2):127-9. [View Abstract]
  43. Fleming JF, Lovisolo CF. Intrastromal corneal ring segments in a patient with previous laser in situ keratomileusis. J Refract Surg. 2000 May-Jun. 16(3):365-7. [View Abstract]
  44. Edelhauser HF. The resiliency of the corneal endothelium to refractive and intraocular surgery. Cornea. 2000 May. 19(3):263-73. [View Abstract]
  45. Holmes-Higgin DK, Burris TE, Lapidus JA, et al. Risk factors for self-reported visual symptoms with Intacs inserts for myopia. Ophthalmology. 2002 Jan. 109(1):46-56. [View Abstract]
  46. Azar RG, Holdbrook MJ, Lemp M, et al. Two-year corneal endothelial cell assessment following INTACS implantation. J Refract Surg. 2001 Sep-Oct. 17(5):542-8. [View Abstract]
  47. Clinch TE, Lemp MA, Foulks GN, et al. Removal of INTACS for myopia. Ophthalmology. 2002 Aug. 109(8):1441-6. [View Abstract]
  48. FDA. Intacs. Summary of safety and effectiveness. FDA. 1999.
  49. Bourcier T, Borderie V, Laroche L. Late bacterial keratitis after implantation of intrastromal corneal ring segments. J Cataract Refract Surg. 2003 Feb. 29(2):407-9. [View Abstract]
  50. Hofling-Lima AL, Branco BC, Romano AC, et al. Corneal infections after implantation of intracorneal ring segments. Cornea. 2004 Aug. 23(6):547-9. [View Abstract]
  51. Burris TE, Holmes-Higgin DK, Silvestrini TA. Lamellar intrastromal corneal tattoo for treating iris defects (artificial iris). Cornea. 1998 Mar. 17(2):169-73. [View Abstract]
  52. Ruckhofer J, Twa MD, Schanzlin DJ. Clinical characteristics of lamellar channel deposits after implantation of intacs. J Cataract Refract Surg. 2000 Oct. 26(10):1473-9. [View Abstract]
  53. Holmes-Higgin DK, Burris TE. Corneal surface topography and associated visual performance with INTACS for myopia: phase III clinical trial results. The INTACS Study Group. Ophthalmology. 2000 Nov. 107(11):2061-71. [View Abstract]
  54. Asbell PA, Ucakhan OO. Long-term follow-up of Intacs from a single center. J Cataract Refract Surg. 2001 Sep. 27(9):1456-68. [View Abstract]
  55. Levinger S, Pokroy R. Keratoconus managed with intacs: one-year results. Arch Ophthalmol. 2005 Oct. 123(10):1308-14. [View Abstract]
  56. Nose W, Neves RA, Burris TE, et al. Intrastromal corneal ring: 12-month sighted myopic eyes. J Refract Surg. 1996 Jan-Feb. 12(1):20-8. [View Abstract]
  57. Nosé W, Neves RA, Schanzlin DJ, et al. Intrastromal corneal ring--one-year results of first implants in humans: a preliminary nonfunctional eye study. Refract Corneal Surg. 1993 Nov-Dec. 9(6):452-8. [View Abstract]
  58. Kymionis GD, Siganos CS, Kounis G, et al. Management of post-LASIK corneal ectasia with Intacs inserts: one-year results. Arch Ophthalmol. 2003 Mar. 121(3):322-6. [View Abstract]
  59. Barbara A, Shehadeh-Masha'our R, Zvi F, et al. Management of pellucid marginal degeneration with intracorneal ring segments. J Refract Surg. 2005 May-Jun. 21(3):296-8. [View Abstract]
  60. Mularoni A, Torreggiani A, di Biase A, et al. Conservative treatment of early and moderate pellucid marginal degeneration: a new refractive approach with intracorneal rings. Ophthalmology. 2005 Apr. 112(4):660-6. [View Abstract]
  61. Rodriguez-Prats J, Galal A, Garcia-Lledo M, et al. Intracorneal rings for the correction of pellucid marginal degeneration. J Cataract Refract Surg. 2003 Jul. 29(7):1421-4. [View Abstract]
  62. Burris TE, Baker PC, Ayer CT, et al. Flattening of central corneal curvature with intrastromal corneal rings of increasing thickness: an eye-bank eye study. J Cataract Refract Surg. 1993. 19 Suppl:182-7. [View Abstract]
  63. Piñero DP, Alio JL. Intracorneal ring segments in ectatic corneal disease - a review. Clin Experiment Ophthalmol. 2010 Mar. 38(2):154-67. [View Abstract]
  64. Durrie DS, Vande Garde TL. LASIK enhancements. Int Ophthalmol Clin. 2000 Summer. 40(3):103-10. [View Abstract]
  65. Assil KK. Intacs as an Enhancement Procedure. AAO Refractive Surgery Subspecialty Day Manual. 2000.
  66. Mediphacos Keraring intrastromal corneal ring segments. Mediphacos. Available at http://www.mediphacos.com.br/en/produtos_implanteIntraEstromalKeraring.asp. Accessed: August 15, 2013.
  67. Daxer A. Biomechanics of Corneal Ring Implants. Cornea. 2015 Nov. 34 (11):1493-8. [View Abstract]
  68. Elsaftawy HS, Ahmed MH, Saif MY, Mousa R. Sequential Intracorneal Ring Segment Implantation and Corneal Transepithelial Collagen Cross-Linking in Keratoconus. Cornea. 2015 Nov. 34 (11):1420-6. [View Abstract]
  69. Ibares-Frías L, Gallego P, Cantalapiedra-Rodriguez R, Merayo-Lloves J, Martínez-García MC. Clinical, Refractive and Histological Reversibility of Corneal Additive Surgery in Deep Stroma in an Animal Model. Curr Eye Res. 2016 Feb 18. 1-10. [View Abstract]
  70. Al-Tuwairqi WS, Osuagwu UL, Razzouk H, Ogbuehi KC. One-Year Clinical Outcomes of a Two-Step Surgical Management for Keratoconus-Topography-Guided Photorefractive Keratectomy/Cross-Linking After Intrastromal Corneal Ring Implantation. Eye Contact Lens. 2015 Nov. 41 (6):359-66. [View Abstract]
  71. Hashemian MN, Zare MA, Mohammadpour M, Rahimi F, Fallah MR, Panah FK. Outcomes of Single Segment Implantation of Conventional Intacs versus Intacs SK for Keratoconus. J Ophthalmic Vis Res. 2014 Jul-Sep. 9 (3):305-9. [View Abstract]
  72. Avni-Zauberman N, Rootman DS. Cross-linking and intracorneal ring segments--review of the literature. Eye Contact Lens. 2014 Nov. 40 (6):365-70. [View Abstract]
  73. Alio JL, Vega-Estrada A, Esperanza S, Barraquer RI, Teus MA, Murta J. Intrastromal corneal ring segments: how successful is the surgical treatment of keratoconus?. Middle East Afr J Ophthalmol. 2014 Jan-Mar. 21 (1):3-9. [View Abstract]

Graphic representation of the intracorneal ring segments in place. Reprinted with permission of Addition Technology Inc.

Intacs microthin prescription inserts treat mild myopia. Reprinted with permission of Addition Technology Inc.

KeraVision Intacs microthin prescription inserts. Reprinted with permission of Addition Technology Inc.

KeraVision Intacs microthin prescription inserts. Intracorneal ring segments. Reprinted with permission of Addition Technology Inc.

The 1.2-mm radial incision is made with a diamond knife at the edge of a 7-mm optical zone. The diamond knife is set for approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.

Rotation of the dissector creates the tunnel in the peripheral cornea into which an Intacs insert will be placed. Reprinted with permission of Addition Technology Inc.

The first Intacs insert is placed in the tunnel. Reprinted with permission of Addition Technology Inc.

An Intacs insert in place at approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.

KeraVision Intacs microthin prescription inserts. Reprinted with permission of Addition Technology Inc.

KeraVision Intacs microthin prescription inserts. Intracorneal ring segments. Reprinted with permission of Addition Technology Inc.

The 1.2-mm radial incision is made with a diamond knife at the edge of a 7-mm optical zone. The diamond knife is set for approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.

Rotation of the dissector creates the tunnel in the peripheral cornea into which an Intacs insert will be placed. Reprinted with permission of Addition Technology Inc.

The first Intacs insert is placed in the tunnel. Reprinted with permission of Addition Technology Inc.

An Intacs insert in place at approximately two thirds of corneal depth. Reprinted with permission of Addition Technology Inc.

Graphic representation of the intracorneal ring segments in place. Reprinted with permission of Addition Technology Inc.

Intacs microthin prescription inserts treat mild myopia. Reprinted with permission of Addition Technology Inc.

Design Technique
360° ICRRadial incision
360° ICRCircumferential incision
Gapped ICRRadial incision
Intacs insertsRadial incision
Intacs thickness (mm) Predicted nominal correction (D) Recommended prescribing range (D)
0.25-1.30-1.00 to -1.625
0.30-2.00-1.75 to -2.25
0.35-2.70-2.375 to -3.00